$119 Million is the total value of ACUTA CAPITAL PARTNERS, LLC's 51 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 98.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FOLD | Buy | AMICUS THERAPEUTICS | $21,374,000 | +57.3% | 1,964,565 | +20.3% | 18.00% | +96.1% |
| LBIO | New | LION BIOTECHNOLOGIES | $8,104,000 | – | 669,196 | +100.0% | 6.83% | – |
| CEMP | New | CEMPRA | $5,846,000 | – | 170,400 | +100.0% | 4.92% | – |
| ALIM | Sell | ALIMERA SCIENCES | $5,285,000 | -9.7% | 1,054,809 | -0.2% | 4.45% | +12.5% |
| BEAT | Sell | BIOTELEMETRY | $4,257,000 | -12.3% | 481,069 | -0.6% | 3.59% | +9.3% |
| Sell | EXELIXIS INCnote 4.25% 8/1 | $4,167,000 | +15.3% | 5,474,000 | -15.4% | 3.51% | +43.7% | |
| ASND | New | ASCENDIS PHARMA A Sspons adr | $3,966,000 | – | 228,612 | +100.0% | 3.34% | – |
| ZFGN | Sell | ZAFGEN | $3,961,000 | +28.1% | 100,000 | -0.3% | 3.34% | +59.6% |
| LMAT | Buy | LEMAITRE VASCULAR | $3,907,000 | +10.3% | 466,279 | +0.7% | 3.29% | +37.5% |
| PTX | Sell | PERNIX THERAPEUTICS HLDGS | $3,742,000 | -34.0% | 350,000 | -42.1% | 3.15% | -17.8% |
| OXFD | New | OXFORD IMMUNOTEC GLOBAL PLC | $3,129,000 | – | 222,226 | +100.0% | 2.64% | – |
| INSM | Buy | INSMED | $3,120,000 | +1436.9% | 150,000 | +1040.3% | 2.63% | +1818.2% |
| RRM | Buy | RR MEDIA LTD | $3,106,000 | +7.5% | 405,424 | +1.0% | 2.62% | +33.9% |
| BBW | Buy | BUILD A BEAR WORKSHOP | $2,948,000 | +65.2% | 150,000 | +69.0% | 2.48% | +105.9% |
| CASM | Buy | CAS MED SYS | $2,884,000 | +234.6% | 2,160,000 | +313.4% | 2.43% | +316.6% |
| IRIX | Buy | IRIDEX | $2,515,000 | +40.0% | 235,517 | +12.7% | 2.12% | +74.5% |
| IWM | Sell | ISHARES TRput | $2,487,000 | -91.0% | 20,000 | -91.3% | 2.10% | -88.7% |
| CRME | Sell | CARDIOME PHARMA | $2,200,000 | -21.6% | 237,600 | -21.7% | 1.85% | -2.3% |
| OFIX | Sell | ORTHOFIX INTL N V | $2,153,000 | +6.8% | 60,000 | -10.5% | 1.81% | +33.1% |
| PODD | New | INSULET | $2,077,000 | – | 62,265 | +100.0% | 1.75% | – |
| SPY | New | SPDR S&P 500 ETF TRput | $2,064,000 | – | 10,000 | +100.0% | 1.74% | – |
| AUPH | New | AURINIA PHARMACEUTICALS | $1,875,000 | – | 430,000 | +100.0% | 1.58% | – |
| FLKS | New | FLEX PHARMA | $1,764,000 | – | 90,000 | +100.0% | 1.49% | – |
| CBMX | Buy | COMBIMATRIX CORPORATION | $1,672,000 | +51.9% | 880,244 | +3.2% | 1.41% | +89.2% |
| AVID | New | AVID TECHNOLOGY | $1,502,000 | – | 100,818 | +100.0% | 1.26% | – |
| New | NEURODERM LTD | $1,385,000 | – | 103,167 | +100.0% | 1.17% | – | |
| INNL | Buy | INNOCOLL AGspons adr | $1,307,000 | +34.2% | 164,459 | +0.2% | 1.10% | +67.3% |
| HSGX | Sell | HISTOGENICS | $1,231,000 | -18.2% | 123,249 | -9.9% | 1.04% | +2.0% |
| CRDC | Buy | CARDICA | $1,146,000 | +11.7% | 1,819,436 | +24.1% | 0.96% | +39.2% |
| BLCM | Sell | BELLICUM PHARMACEUTICALS | $1,019,000 | -3.3% | 43,986 | -3.9% | 0.86% | +20.5% |
| EGOV | New | NIC | $1,010,000 | – | 57,143 | +100.0% | 0.85% | – |
| RXDX | Sell | IGNYTA | $995,000 | -60.7% | 100,000 | -72.9% | 0.84% | -51.0% |
| NXTM | New | NXSTAGE MEDICAL | $928,000 | – | 53,665 | +100.0% | 0.78% | – |
| SRNE | New | SORRENTO THERAPEUTICScall | $925,000 | – | 80,000 | +100.0% | 0.78% | – |
| AVEO | New | AVEO PHARMACEUTICALS | $861,000 | – | 593,872 | +100.0% | 0.72% | – |
| EXEL | New | EXELIXIS INCcall | $846,000 | – | 329,000 | +100.0% | 0.71% | – |
| DYAX | New | DYAX CORPcall | $838,000 | – | 50,000 | +100.0% | 0.71% | – |
| AGRX | New | AGILE THERAPEUTICS | $750,000 | – | 80,959 | +100.0% | 0.63% | – |
| OTIC | New | OTONOMY | $707,000 | – | 20,000 | +100.0% | 0.60% | – |
| CEMI | CHEMBIO DIAGNOSTICS | $590,000 | +3.3% | 146,099 | 0.0% | 0.50% | +28.8% | |
| MOLGY | Sell | MOL GLOBALspons adr | $563,000 | -45.7% | 246,009 | -27.6% | 0.47% | -32.3% |
| KIN | Sell | KINDRED BIOSCIENCES | $536,000 | -58.1% | 75,000 | -56.3% | 0.45% | -47.9% |
| DSCO | New | DISCOVERY LABORATORIES | $468,000 | – | 393,148 | +100.0% | 0.39% | – |
| GNVC | Sell | GENVEC | $456,000 | -38.2% | 154,508 | -56.5% | 0.38% | -23.0% |
| CERS | Sell | CERUS | $417,000 | -78.3% | 100,000 | -67.6% | 0.35% | -73.0% |
| SAGE | New | SAGE THERAPEUTICS | $402,000 | – | 8,000 | +100.0% | 0.34% | – |
| SMLR | New | SEMLER SCIENTIFIC | $403,000 | – | 115,148 | +100.0% | 0.34% | – |
| MRNS | New | MARINUS PHARMACEUTICALS | $325,000 | – | 36,107 | +100.0% | 0.27% | – |
| ZSAN | New | ZOSANO PHARMA | $222,000 | – | 21,956 | +100.0% | 0.19% | – |
| ANGO | New | ANGIODYNAMICS | $178,000 | – | 10,000 | +100.0% | 0.15% | – |
| TXMD | New | THERAPEUTICSMD | $114,000 | – | 18,915 | +100.0% | 0.10% | – |
| ASMB | Exit | ASSEMBLY BIOSCIENCES | $0 | – | -3,800 | -100.0% | -0.02% | – |
| CYHHZ | Exit | COMMUNITY HEALTH SYS INC NEWright 01/27/2016 | $0 | – | -2,963,721 | -100.0% | -0.05% | – |
| Exit | TRILLIUM THERAPEUTICS | $0 | – | -19,000 | -100.0% | -0.12% | – | |
| VCYT | Exit | VERACYTE | $0 | – | -29,024 | -100.0% | -0.19% | – |
| P103PS | Exit | NPS PHARMACEUTICALS | $0 | – | -8,000 | -100.0% | -0.19% | – |
| OXM | Exit | OXFORD IMMUNOTEC GLOBAL PLC | $0 | – | -24,742 | -100.0% | -0.23% | – |
| XNCR | Exit | XENCOR | $0 | – | -22,011 | -100.0% | -0.24% | – |
| P103PS | Exit | NPS PHARMACEUTICALScall | $0 | – | -10,000 | -100.0% | -0.24% | – |
| PSDV | Exit | PSIVIDA | $0 | – | -122,338 | -100.0% | -0.34% | – |
| NSPH | Exit | NANOSPHERE | $0 | – | -1,456,884 | -100.0% | -0.39% | – |
| SQNM | Exit | SEQUENOM | $0 | – | -155,135 | -100.0% | -0.39% | – |
| ATRS | Exit | ANTARES PHARMA | $0 | – | -232,762 | -100.0% | -0.40% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCEScall | $0 | – | -31,500 | -100.0% | -0.48% | – |
| ATHN | Exit | ATHENAHEALTHput | $0 | – | -5,000 | -100.0% | -0.49% | – |
| CEMP | Exit | CEMPRAput | $0 | – | -40,000 | -100.0% | -0.64% | – |
| HRTX | Exit | HERON THERAPEUTICS | $0 | – | -101,050 | -100.0% | -0.69% | – |
| AGEN | Exit | AGENUS | $0 | – | -268,466 | -100.0% | -0.72% | – |
| ZINCQ | Exit | HORSEHEAD HLDG | $0 | – | -68,577 | -100.0% | -0.73% | – |
| PRTK | Exit | PARATEK PHARMACEUTICALS | $0 | – | -29,252 | -100.0% | -0.76% | – |
| AMAG | Exit | AMAG PHARMACEUTICALS | $0 | – | -26,596 | -100.0% | -0.77% | – |
| Exit | ARRAY BIOPHARMA INCnote 3.000% | $0 | – | -1,315,000 | -100.0% | -0.83% | – | |
| CERS | Exit | CERUScall | $0 | – | -200,000 | -100.0% | -0.84% | – |
| FWP | Exit | FORWARD PHARMA A/Sspons adr | $0 | – | -60,730 | -100.0% | -0.86% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCcall | $0 | – | -20,000 | -100.0% | -0.92% | – |
| HPTX | Exit | HYPERION THERAPEUTICS | $0 | – | -60,462 | -100.0% | -0.98% | – |
| DEPO | Exit | DEPOMED | $0 | – | -90,958 | -100.0% | -0.99% | – |
| FRSH | Exit | PAPA MURPHYS HLDGS | $0 | – | -140,462 | -100.0% | -1.10% | – |
| EHTH | Exit | EHEALTH | $0 | – | -69,519 | -100.0% | -1.17% | – |
| VASC | Exit | VASCULAR SOLUTIONS | $0 | – | -74,494 | -100.0% | -1.37% | – |
| HZNP | Exit | HORIZON PHARMA PLC | $0 | – | -167,491 | -100.0% | -1.46% | – |
| ENTA | Exit | ENANTA PHARMACEUTICALS | $0 | – | -44,528 | -100.0% | -1.53% | – |
| RCPT | Exit | RECEPTOS | $0 | – | -18,768 | -100.0% | -1.55% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALScall | $0 | – | -20,000 | -100.0% | -1.61% | – |
| 5100PS | Exit | VOLCANO CORPORATION | $0 | – | -153,436 | -100.0% | -1.85% | – |
| CTIC | Exit | CTI BIOPHARMA | $0 | – | -1,228,111 | -100.0% | -1.96% | – |
| TTPH | Exit | TETRAPHASE PHARMACEUTICALS | $0 | – | -74,803 | -100.0% | -2.01% | – |
| CEMP | Exit | CEMPRAcall | $0 | – | -164,800 | -100.0% | -2.62% | – |
| QQQ | Exit | POWERSHARES QQQ TRUSTput | $0 | – | -70,000 | -100.0% | -4.88% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS INC | 24 | Q1 2023 | 21.2% |
| IRIDEX CORP | 20 | Q3 2019 | 8.1% |
| ARROWHEAD PHARMACEUTICALS INC | 20 | Q2 2023 | 7.9% |
| IMMUNOMEDICS INC | 19 | Q3 2020 | 20.6% |
| VERACYTE INC | 19 | Q3 2019 | 10.1% |
| ASCENDIS PHARMA A S | 18 | Q2 2020 | 7.2% |
| XENON PHARMACEUTICALS INC | 18 | Q3 2022 | 4.6% |
| CAS MED SYS PAR $0.004 | 18 | Q1 2019 | 6.4% |
| APELLIS PHARMACEUTICALS INC | 17 | Q3 2023 | 18.4% |
| KURA ONCOLOGY INC. COMMON STOCK | 17 | Q3 2023 | 8.1% |
View ACUTA CAPITAL PARTNERS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| BCLS Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| Jiya Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| VistaGen Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Larimar Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
| CATALYST BIOSCIENCES, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Aadi Bioscience, Inc. | September 07, 2021 | 1,529,402 | 7.2% |
| Kadmon Holdings, Inc. | February 14, 2020 | 7,373,333 | 4.6% |
| IRIDEX CORPSold out | November 13, 2019 | 0 | 0.0% |
| ASSEMBLY BIOSCIENCES, INC. | February 14, 2019 | 718,500 | 2.8% |
| CAS MEDICAL SYSTEMS INC | February 14, 2019 | 5,263,508 | 18.2% |
View ACUTA CAPITAL PARTNERS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View ACUTA CAPITAL PARTNERS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.